Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for Bio-Techne (TECH) over the last 10 years, with Q2 2025 value amounting to $66.0 million.

  • Bio-Techne's Long-Term Debt Issuances changed N/A to $66.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $104.0 million, marking a year-over-year decrease of 5377.78%. This contributed to the annual value of $104.0 million for FY2025, which is 5377.78% down from last year.
  • Bio-Techne's Long-Term Debt Issuances amounted to $66.0 million in Q2 2025.
  • Bio-Techne's Long-Term Debt Issuances' 5-year high stood at $449.7 million during Q3 2022, with a 5-year trough of $10.0 million in Q3 2021.
  • In the last 4 years, Bio-Techne's Long-Term Debt Issuances had a median value of $65.5 million in 2023 and averaged $129.5 million.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first skyrocketed by 439661.0% in 2022, then tumbled by 6441.76% in 2023.
  • Over the past 4 years, Bio-Techne's Long-Term Debt Issuances (Quarter) stood at $40.0 million in 2021, then surged by 1024.15% to $449.7 million in 2022, then plummeted by 85.54% to $65.0 million in 2023, then increased by 1.54% to $66.0 million in 2025.
  • Its Long-Term Debt Issuances stands at $66.0 million for Q2 2025, versus $38.0 million for Q1 2025 and $65.0 million for Q4 2023.